T1	intervention 0 7	Aspirin
T2	No-of-participants 643 646	144
T3	eligibility 647 675	healthy postmenopausal women
T4	eligibility 31 51	postmenopausal women
T5	duration 710 719	2005-2007
T6	outcome-Measure 1016 1079	differences in the geometric mean outcome changes at six months
T7	control 1100 1107	placebo
T8	average-age 1186 1190	59.4
T9	outcome 1321 1344	serum estrogens or SHBG
T10	outcome 1413 1431	Stratifying by BMI
